Add BrightSurf on Google Email

New AI tool developed by Stowers Institute and Helmholtz Munich scientists predicts how cells choose their future — helping uncover hidden drivers of development

Researchers developed RegVelo, an AI framework that models cellular dynamics and gene regulation to predict cellular fate decisions. The model traces developmental trajectories and simulates regulatory interactions, providing insights into hidden drivers of development and potential therapeutic targets.

A novel technology to explore peptides as drug targets with high precision without using cells

Researchers developed a novel method to immobilize proteins onto magnetic microbeads, allowing precise measurement of binding strength and efficient selection of target peptides. The technique achieved a 10,000-fold concentration in a single sorting step, significantly enhancing the efficiency of drug discovery research.

SourceInnovation Center of NanoMedicine·JournalPNAS Nexus·TypeExperimental study·DateFeb 26, 2026

Diagnostics.AI launches industry’s first CE-IVDR certified transparent AI platform for molecular diagnostics as regulatory deadlines take fffect

Diagnostics.AI has launched the industry's first fully-transparent machine learning platform for clinical real-time PCR diagnostics, delivering algorithmic transparency and per-test auditability. The platform is CE-IVDR certified and backed by over 15 years of experience and millions of successfully processed samples.

Sourcediagnostics.ai ltd·TypeNews article·DateMay 29, 2025

Adaptive defenses against malicious jumping genes

Scientists found that piRNA rapidly catches up with changes in jumping genes, improving efficiency through a competition between sites. This unique property of piRNA has implications for medical research and potential diagnostic or therapeutic strategies against unwanted genetic mutations.

SourceUniversity of Tokyo·JournalMolecular Cell·TypeExperimental study·DateMar 20, 2025

New CRISPR-based diagnostic test detects pathogens in blood without amplification

Researchers developed a CRISPR-based diagnostic test that rapidly detects low levels of pathogen genetic material in blood without nucleic acid amplification. The test demonstrated unprecedented sensitivity and could be used to develop highly sensitive CRISPR-based diagnostic tests for detecting pathogens in minutes.

SourceUniversity of Illinois Grainger College of Engineering·JournalProceedings of the National Academy of Sciences·DateMar 14, 2025

Bacterial single-cell whole genome sequencing overhauled by engineered polymerase

A new process developed by researchers at the Chinese Academy of Sciences Headquarters greatly reduces bias in gene amplification, enabling high-coverage genome sequencing from single bacterial cells. The improved method uses an engineered phi29 DNA polymerase that is more efficient and robust than traditional versions.

SourceChinese Academy of Sciences Headquarters·JournalFrontiers in Bioengineering and Biotechnology·DateJul 24, 2023

DNA test could broaden access to cervical cancer screening

Rice University engineers developed a low-cost, point-of-care DNA test for HPV infections that can be used to screen for cervical cancer. The test, which requires just two pieces of equipment and delivers results in 45 minutes, has the potential to make cervical cancer screening more accessible in low- and middle-income countries.

SourceRice University·JournalScience Translational Medicine·TypeExperimental study·DateJun 21, 2023

Genes & Cancer | Systems biology network reveals the correlation between COX-2 expression and Ch 7q copy number alterations in Ch 11q-deleted pediatric neuroblastoma tumors

Researchers analyzed COX-2 levels and segmental chromosome aberrations in pediatric neuroblastoma tumor samples. Positive correlations between pre-CT Ch 7q gain and COX-2 expression were found, as well as negative correlations between Ch 7q gain and Ch 11q deletion.

SourceImpact Journals LLC·JournalGenes & Cancer·TypeData/statistical analysis·DateDec 16, 2022